Mechanisms of the protective action of diethyldithiocarbamate-iron complex on acute cardiac allograft rejection
- 1 May 2003
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 284 (5) , H1542-H1551
- https://doi.org/10.1152/ajpheart.00913.2002
Abstract
In this study, we examined the actions of diethyldithiocarbamate-iron (DETC-Fe) complex in acute graft rejection heterotopically transplanted rat hearts. Chronic treatment with DETC-Fe inhibited the increase in plasma nitric oxide (NO) metabolites and nitrosylation of myocardial heme protein as determined by electron paramagnetic resonance (EPR) spectroscopy. Pulse injection with DETC-Fe normalized NO metabolites. We verified intragraft trapping of NO in vivo by pulse injection with DETC-Fe by the detection within allografts of an anisotropic triplet EPR signal for DETC-Fe-NO adduct with resonance positions ( g tensor factors for perpendicular and parallel components, respectively g ⊥ = 2.038 and g ∥ = 2.02; hyperfine coupling of 12.5 G). DETC-Fe prolonged graft survival and decreased histological rejection scores. DNA binding activity for nuclear factor (NF)-κB and activator protein-1 was increased in allografts and prevented by DETC-Fe. Abrogation of the activation of NF-κB by DETC-Fe was associated with increased IκBα inhibitory protein. Western blotting and RT-PCR analysis revealed that DETC-Fe inhibited inducible NO synthase protein and gene expression. Gene expression for the proinflammatory cytokine interferon-γ was also decreased by DETC-Fe. Thus DETC-Fe limits NF-κB-dependent gene expression and possesses significant immunosuppressive properties.Keywords
This publication has 52 references indexed in Scilit:
- Inhibitory effect of DCDC on lipopolysaccharide-induced nitric oxide synthesis in RAW 264.7 cells.Life Sciences, 2001
- Prolongation of Cardiac Allograft Survival Using Dendritic Cells Treated with NF-κB Decoy OligodeoxyribonucleotidesMolecular Therapy, 2000
- NOX, a novel nitric oxide scavenger, reduces bacterial translocation in rats after endotoxin challengeAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1999
- MYOCARDIAL NUCLEAR FACTOR-??B ACTIVITY AND NITRIC OXIDE PRODUCTION IN REJECTING CARDIAC ALLOGRAFTS1Transplantation, 1998
- In Murine 3T3 Fibroblasts, Different Second Messenger Pathways Resulting in the Induction of NO Synthase II (iNOS) Converge in the Activation of Transcription Factor NF-κBPublished by Elsevier ,1996
- Mechanistic aspects of NF-κB regulation: The emerging role of phosphorylation and proteolysisImmunity, 1995
- Effects of immunosuppressive therapy on expression of inducible nitric oxide synthase (iNOS) during cardiac allograft rejectionInternational Journal of Cardiology, 1995
- Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthaseEuropean Journal of Pharmacology, 1995
- Nω-monomethyl-l-arginine inhibits nitric oxide production in murine cardiac allografts but does not affect graft rejectionBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1994
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994